R L Bush1, W C Pevec, J W Holcroft. 1. Department of Surgery, University of California Davis Medical Center, Sacramento 95817, USA.
Abstract
BACKGROUND:Patients undergoing major arterial reconstruction have traditionally been transfused with red blood cells to keep hemoglobin concentrations above 10 g/dL in order to prevent anemia-induced myocardial ischemia. There are no data to support this practice. The hypothesis that vascular patients will tolerate a hemoglobin concentration of 9 g/dL was examined. METHODS:Ninety-nine patients undergoing elective aortic and infrainguinal arterial reconstructions were prospectively randomized preoperatively to receive transfusions to maintain a hemoglobin level of either 10 g/dL or 9 g/dL. RESULTS: Despite significantly different postoperative hemoglobin levels of 11.0 +/- 1.2 versus 9.8 +/- 1.3 g/dL (P <0.0001), there were no differences in mortality or cardiac morbidity rates or length of hospital stay. There were no differences in hemodynamic parameters. Oxygen delivery was lower in the group with lower hemoglobin levels, but there was no difference in O2 consumption between the groups. CONCLUSIONS: A lower hemoglobin concentration was tolerated without adverse clinical outcome. Patients did not compensate for anemia by increased myocardial work, but by increasing O2 extraction in the peripheral tissues.
RCT Entities:
BACKGROUND:Patients undergoing major arterial reconstruction have traditionally been transfused with red blood cells to keep hemoglobin concentrations above 10 g/dL in order to prevent anemia-induced myocardial ischemia. There are no data to support this practice. The hypothesis that vascular patients will tolerate a hemoglobin concentration of 9 g/dL was examined. METHODS: Ninety-nine patients undergoing elective aortic and infrainguinal arterial reconstructions were prospectively randomized preoperatively to receive transfusions to maintain a hemoglobin level of either 10 g/dL or 9 g/dL. RESULTS: Despite significantly different postoperative hemoglobin levels of 11.0 +/- 1.2 versus 9.8 +/- 1.3 g/dL (P <0.0001), there were no differences in mortality or cardiac morbidity rates or length of hospital stay. There were no differences in hemodynamic parameters. Oxygen delivery was lower in the group with lower hemoglobin levels, but there was no difference in O2 consumption between the groups. CONCLUSIONS: A lower hemoglobin concentration was tolerated without adverse clinical outcome. Patients did not compensate for anemia by increased myocardial work, but by increasing O2 extraction in the peripheral tissues.
Authors: Martin David Berger; Bernhard Gerber; Kornelius Arn; Oliver Senn; Urs Schanz; Georg Stussi Journal: Haematologica Date: 2011-09-20 Impact factor: 9.941
Authors: Santiago R Leal-Noval; Manuel Muñoz; Marisol Asuero; Enric Contreras; José A García-Erce; Juan V Llau; Victoria Moral; José A Páramo; Manuel Quintana Journal: Blood Transfus Date: 2013-06-17 Impact factor: 3.443
Authors: I Cortés-Puch; B M Wiley; J Sun; H G Klein; J Welsh; R L Danner; P Q Eichacker; C Natanson Journal: Transfus Med Date: 2018-04-19 Impact factor: 2.019
Authors: Martin D Zielinski; Gregory A Wilson; Pamela M Johnson; Stephanie F Polites; Donald H Jenkins; W Scott Harmsen; John B Holcomb; Charles E Wade; Deborah J Del Junco; Erin E Fox; James R Stubbs Journal: Surgery Date: 2016-07-20 Impact factor: 3.982
Authors: Stuart A McCluskey; Wing K Cheung; Rita Katznelson; Humara Poonawala; Ludwik Fedorko; George Djaiani; Bobby Mehta; Keyvan Karkouti Journal: Eur J Clin Pharmacol Date: 2008-10-30 Impact factor: 2.953